Veeva Systems Launches Veeva Falcon Safety for Biopharmaceutical Companies

Veeva Systems, a leading provider of cloud-based solutions for the life sciences industry, has launched Veeva Falcon Safety, a new safety operations platform designed to streamline the collection, processing, and tracking of adverse events. This solution aims to reduce costs, accelerate processes, and ensure compliance for biopharmaceutical companies of all sizes.

Veeva Falcon Safety integrates seamlessly with Veeva Safety and is compatible with any E2B-compliant safety system, including Oracle Argus and ArisGlobal LifeSphere MultiVigilance. The platform will be available to early adopters in November 2026, as part of Veeva AI, the company’s suite of artificial intelligence solutions tailored for the life sciences sector.

“Working closely with global dossier managers, pharmacovigilance experts, and safety specialists, we have developed Veeva Safety,” said Marius Mortensen, Veeva’s Vice President of Falcon Products. “With Veeva Falcon Safety, we are excited to enhance this partnership and help the industry revolutionize its safety procedures.”

Veeva Systems offers a cloud-based platform dedicated to the life sciences industry, encompassing applications, agents, data, and consulting services. The company serves over 1,500 clients, including the world’s largest biopharmaceutical companies and emerging biotechs. Veeva is committed to balancing the interests of all stakeholders, including clients, employees, shareholders, and the industries it serves.

Veeva Falcon Safety is part of Veeva AI, a collection of AI solutions designed to support the life sciences sector. By ensuring compatibility with E2B-compliant systems, the new platform promises to simplify and standardize safety operations for biopharmaceutical companies.

“We are confident that Veeva Falcon Safety will provide a robust and flexible solution for our clients,” said Mortensen. “By leveraging our expertise and collaboration with industry experts, we aim to deliver a product that meets the diverse needs of the life sciences community.”

The launch of Veeva Falcon Safety represents a significant advancement in the management of safety data within the biopharmaceutical industry, promising to enhance efficiency and compliance across the sector.